Aromatase Inhibitors: Startling New Study Shows Dramatic Reduction in Recurrence Rates
If you finished taking tamoxifen for ER-receptive breast cancer even as long as 7 years ago, you might be able to do something right now to cut your risk for another bout of cancer by as much as 82%. The March 10 edition of the Journal of Clinical Oncology features results of a study that could impact millions of breast cancer... Read more
